Showing 1141-1150 of 7862 results for "".
The Road Map to Success: When Does it Make Sense to Have a Dermatology PA?
https://practicaldermatology.com/topics/practice-management/the-road-map-to-success-when-does-it-make-sense-to-have-a-dermatology-pa/23235/Adding a new provider can increase access and boost the bottom line. But how do you choose?Understanding a New Method of Assessing Psoriasis Severity
https://practicaldermatology.com/columns/clinical-focus-1/understanding-a-new-method-of-assessing-psoriasis-severity/23157/New method aims to improve access to systemic psoriasis therapy.The History of the SDPA: Celebrating 25 Years
https://practicaldermatology.com/series/sdpa-corner/the-history-of-the-sdpa-celebrating-25-years/23065/From an original 49 members, the SDPA has grown to include 3,500 dermatology PAs and introduced numerous initiatives to support dermatology.Dermatologic Disparities: Essential Considerations in Patient Care
https://practicaldermatology.com/topics/skin-of-color/dermatologic-disparities-essential-considerations-in-patient-care/22987/A brief review of dermatologic healthcare disparities in the lesbian, gay, bisexual, and transgender (LGBT) community and racial minority groups, including African Americans, Hispanics, and Asian/Pacific Islanders.Neurotoxins on the Horizon: Bonti and Beyond
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/neurotoxins-on-the-horizon-bonti-and-beyond/20321/Allergan's acquisition of Bonti highlights the burgeoning potential of the injectable neurotoxin market.Currents: Use as Directed
https://practicaldermatology.com/topics/psoriasis/currents-use-as-directed/21082/Strategies to improve outcomes and enhance adherence in psoriasis, acne, eczema, and aestheticsGoal Alignment: Complementary Goals Produce Desired Practice Outcomes
https://practicaldermatology.com/topics/practice-management/goal-alignment-complementary-goals-produce-desired-practice-outcomes/21493/Suggested steps managers can take to increase efficiency and improve productivity.Cosmetics Challenge: Going with the Flow: An Overview and Clinical Discussion of The Rheology of Soft Tissue Fillers, Part 1 of 2
https://practicaldermatology.com/topics/general-topics/cosmetics-challenge-going-with-the-flow-an-overview-and-clinical-discussion-of-the-rheology-of-soft-tissue-fillers-part-1-of-2/21890/Flow properties and the clinical behavior that these properties predict can be important factors that help clinicians refine and individualize treatment with dermal fillers.Understanding the Structure, Function, and Strategies for Repair of the Epidermal Barrier
https://practicaldermatology.com/topics/general-topics/PD0509_08-php/22830/Recent research has improved our understanding of barrier function and opened new therapeutic avenues.Upadacitinib and Cardiovascular Events in AD
https://practicaldermatology.com/issues/october-2025/upadacitinib-and-cardiovascular-events-in-ad/39755/A recent review examined whether upadacitinib, a selective Janus kinase 1 (JAK1) inhibitor approved for atopic dermatitis (AD) and other chronic inflammatory diseases, may—despite a boxed warning to the contrary—confer cardioprotective and thromboprotective effects.